ReviewPharmaceuticals (Basel, Switzerland)2025

Phenotyping the Use of Cangrelor in Percutaneous Coronary Interventions.

Nikolaos Pyrpyris et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.